Bristol-Myers Squibb

Bristol Myers Squibb Closes $13.1 Billion Acquisition of MyoKardia
Motley Fool
Tue, 11/17/20 - 11:11 pm
Bristol-Myers Squibb
MyoKardia
M&A
Bristol Myers' $9 Celgene CVR is teetering on the brink of disaster as the FDA delays the liso-cel application yet again
Endpoints
Mon, 11/16/20 - 10:43 pm
Bristol-Myers Squibb
CVRs
Celgene
M&A
A cancer vaccine that might work? Moderna posts 'promising' early snapshot for Merck-partnered program and raids Bristol Myers for a new cancer R&D chief
Endpoints
Wed, 11/11/20 - 11:02 am
Moderna Therapeutics
MRNA
vaccines
cancer vaccines
mRNA-4157
Bristol-Myers Squibb
Could an FDA inspection scupper CVR deadline for BMS’ liso-cel?
Pharmaforum
Fri, 11/6/20 - 09:47 am
Bristol-Myers Squibb
liso-cel
CVRs
How Bristol Myers Squibb Beat Wall Street Estimates in Q3
Motley Fool
Fri, 11/6/20 - 12:39 am
Bristol-Myers Squibb
earnings
Bristol Myers Squibb execs tout progress on Zeposia, Reblozyl and Onureg launches
Fierce Pharma
Fri, 11/6/20 - 12:38 am
Celgene
Bristol-Myers Squibb
Zeposia
Reblozyl
Onureg
Why AstraZeneca, Bristol Myers Squibb, and Eli Lilly Stocks Jumped Today
Motley Fool
Wed, 11/4/20 - 11:02 pm
pharma stocks
2020 Presidential election
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
[video+transcript]Here's What's Behind Bristol Myers Squibb's Huge Acquisitions
Motley Fool
Wed, 11/4/20 - 10:12 am
Bristol-Myers Squibb
M&A
Celgene
MyoKardia
Bristol Myers' psoriasis drug beats Amgen rival in phase 3
Fierce Biotech
Tue, 11/3/20 - 10:49 am
Bristol-Myers Squibb
deucravacitinib
Amgen
Otezla
clinial trials
plaque psoriasis
Jounce shares crash after it abandons immunotherapy combination trial
Pharmaforum
Tue, 11/3/20 - 10:24 am
Jounce Therapeutics
non-small cell lung cancer
Bristol-Myers Squibb
Yervoy
Eliquis partners BMS and Pfizer join the pharma crowd urging doctor visits during COVID-19
Fierce Pharma
Mon, 11/2/20 - 10:29 am
Pfizer
Bristol-Myers Squibb
Eliquis
DTC advertising
pandemic
COVID-19
Go or no go? Big decisions loom for Bristol and Sanofi
EP Vantage
Fri, 10/30/20 - 10:12 am
FDA
Bristol-Myers Squibb
aducanumab
Sanofi
sutimlimab
Y-mAbs
Danyelza
Bristol Myers, insitro ally to apply machine learning to ALS R&D
Fierce Biotech
Wed, 10/28/20 - 10:35 am
Bristol-Myers Squibb
Insitro
machine learning
ALS
artificial intelligence
These 2 Pharmas Have Made Their Pipelines a Competitive Advantage
Motley Fool
Tue, 10/27/20 - 10:33 am
Merck
Bristol-Myers Squibb
competition
FDA kicks off review of second kidney cancer combo based on BMS’ Opdivo
Pharmaforum
Tue, 10/20/20 - 10:33 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Bristol Myers Squibb hematology chief talks COVID-19 challenges, opportunities in blood cancer therapies
Fierce Pharma
Tue, 10/13/20 - 09:57 pm
Bristol-Myers Squibb
hematology
COVID-19
Bristol Myers Squibb's Zeposia boosts remission rates over placebo in ulcerative colitis patients
Fierce Pharma
Sun, 10/11/20 - 10:29 pm
Bristol-Myers Squibb
Zeposia
ulcerative colitis
clinical trials
Pharmacquired: Splashy deals belie a shallow pool of heart drugs left to acquire
BioPharma Dive
Thu, 10/8/20 - 11:16 pm
M&A
cardiology
Bristol-Myers Squibb
MyoKardia
Novartis
The Medicines Company
Celgene shareholders are parsing blurry photos in search of a payday
Stat
Thu, 10/8/20 - 10:34 am
Celgene
Bristol-Myers Squibb
FDA
M&A
Bristol Myers Squibb Announces Phase III Results Exploring the Potential of Opdivo
BioSpace
Wed, 10/7/20 - 11:41 pm
Bristol-Myers Squibb
clinical trials
non-small cell lung cancer
Opdivo

Pages